Medistim ASA (MEDI) — Tangible Net Worth Ratio
Medistim ASA (MEDI) has a Tangible Net Worth Ratio of 83.7% as of June 2025. This metric is calculated by deducting intangible assets (Nkr62.45 Million) from net assets (Nkr383.81 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Medistim ASA current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Medistim ASA Tangible Net Worth Ratio (2004–2024)
This chart shows how Medistim ASA's Tangible Net Worth Ratio has changed across 21 annual periods from 2004 to 2024. As of June 2025, the ratio stands at 83.7%, reflecting net assets of Nkr383.81 Million with intangible assets of Nkr62.45 Million NOK. See Medistim ASA (MEDI) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Medistim ASA (2004–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Medistim ASA from 2004 to 2024, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Medistim ASA (MEDI) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (NOK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.3% | Nkr436.61 Million | Nkr55.61 Million | Nkr574.97 Million | ▼ -4.9 pp |
| 2023 | 92.1% | Nkr397.94 Million | Nkr31.25 Million | Nkr505.72 Million | ▼ -1.9 pp |
| 2022 | 94.0% | Nkr367.69 Million | Nkr21.94 Million | Nkr482.66 Million | ▼ -0.7 pp |
| 2021 | 94.8% | Nkr306.05 Million | Nkr16.04 Million | Nkr403.24 Million | ▲ +2.0 pp |
| 2020 | 92.8% | Nkr256.85 Million | Nkr18.56 Million | Nkr345.82 Million | ▲ +2.9 pp |
| 2019 | 89.9% | Nkr236.86 Million | Nkr24.04 Million | Nkr336.11 Million | ▲ +2.2 pp |
| 2018 | 87.6% | Nkr206.71 Million | Nkr25.61 Million | Nkr269.59 Million | ▲ +3.1 pp |
| 2017 | 84.5% | Nkr182.98 Million | Nkr28.36 Million | Nkr251.06 Million | ▲ +5.1 pp |
| 2016 | 79.4% | Nkr166.70 Million | Nkr34.40 Million | Nkr217.05 Million | ▲ +3.0 pp |
| 2015 | 76.3% | Nkr156.16 Million | Nkr36.98 Million | Nkr218.44 Million | ▲ +1.3 pp |
| 2014 | 75.0% | Nkr139.10 Million | Nkr34.72 Million | Nkr203.49 Million | ▼ -0.5 pp |
| 2013 | 75.6% | Nkr121.64 Million | Nkr29.71 Million | Nkr168.39 Million | ▼ -6.3 pp |
| 2012 | 81.9% | Nkr115.17 Million | Nkr20.90 Million | Nkr151.87 Million | ▲ +2.2 pp |
| 2011 | 79.6% | Nkr106.89 Million | Nkr21.76 Million | Nkr149.63 Million | ▼ -1.6 pp |
| 2010 | 81.2% | Nkr107.83 Million | Nkr20.23 Million | Nkr145.94 Million | ▼ -0.7 pp |
| 2009 | 82.0% | Nkr106.29 Million | Nkr19.15 Million | Nkr145.63 Million | ▼ -1.7 pp |
| 2008 | 83.7% | Nkr95.46 Million | Nkr15.61 Million | Nkr145.38 Million | ▼ -4.7 pp |
| 2007 | 88.3% | Nkr93.83 Million | Nkr10.94 Million | Nkr128.79 Million | ▼ -0.9 pp |
| 2006 | 89.3% | Nkr74.06 Million | Nkr7.94 Million | Nkr119.15 Million | ▼ -6.4 pp |
| 2005 | 95.7% | Nkr67.41 Million | Nkr2.92 Million | Nkr85.00 Million | ▼ -3.0 pp |
| 2004 | 98.6% | Nkr61.71 Million | Nkr847.00K | Nkr74.19 Million | — |